Navigation Links
YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
Date:2/13/2009

MISSISSAUGA, ON, Feb. 13 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today reported operational and financial results for the second quarter of fiscal 2009, ended December 31, 2008.

"During the quarter we prepared to initiate our two randomized Phase II trials for nimotuzumab, which concentrate on two forms of cancer typically treated with radiation-containing regimens. These trials are the cornerstone of YM's registration program for this drug, driven by prior data indicating nimotuzumab's potential to maximize the benefits of radiotherapy while avoiding the toxic side-effects of the other EGFR-targeting drugs," said David Allan, Chairman and CEO of YM BioSciences. "In addition to YM's internal clinical strategy, we continue to benefit from the network of cooperative relationships for the development of nimotuzumab which is undertaking a broad, late-stage, clinical program for this drug."

    Highlights for the second quarter of Fiscal 2009:

    -   YM received clearance from Canadian regulatory authorities to
        initiate two Phase II, double-blind, randomized trials for its EGFR-
        targeting antibody, nimotuzumab, in combination with radiation-based
        treatments. Enrolment for both trials, one in patients with non-small
        cell lung cancer (NSCLC) and the other in patients with brain
        metastases from NSCLC, is expected to be initiated in Canada in the
        first quarter of calendar 2009 and YM anticipates expanding the
        trials into other countries.
    -   The National Cancer Centre of Singapore (NCCS) selected nimotuzumab
        for evaluation in the adjuvant setting in a multinational Phase III
        trial of more than 700 patients with cancers of the head and neck,
        citing the drug's preferential safety profil
'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
2. Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
3. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results
5. BD Biosciences to Distribute FCS Express
6. MichBio Will Publish 2009 Michigan Biosciences Directory and Resource Guide
7. Cell Biosciences Introduces Kits for Oncoprotein Analysis
8. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
9. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
10. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
11. Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  LABSCO, the leading ... products to hospitals, physician office laboratories and alternate ... October 1, 2014, it will serve as Siemens ... market segments and as a semi-exclusive sales distributor ... contiguous United States . LABSCO ...
(Date:9/16/2014)... 2014 BCC Research reveals in ... CELLS , the global market for stem cells is ... with a five-year compound annual growth rate (CAGR) of ... Americas with growth projections of $2.2 billion in 2014 ... http://photos.prnewswire.com/prnh/20140805/700528) , Unlike other potential applications of ...
(Date:9/15/2014)... 15, 2014   Global Science & Technology, ... products and services for satellite and weather systems, ... Integrated Services (OASIS) from the General Services Administration ... to provide the government best-value solutions for complex ... category in Pool 4. The OASIS SB award ...
(Date:9/15/2014)... from North Carolina State University have developed a technique ... applying very low voltages, opening the door to a ... technologies. The technique hinges on the fact that the ... deposited or removed acts as a surfactant, lowering ... fluid. , The researchers used a liquid metal alloy ...
Breaking Biology Technology:LABSCO Secures Alliance With Siemens Healthcare Diagnostics 2LABSCO Secures Alliance With Siemens Healthcare Diagnostics 3Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 2Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% CAGR 3Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Researchers control surface tension to manipulate liquid metals 2
... Jan. 19, 2012  SynCardia Systems, Inc. ( www.syncardia.com ... Heart, announced today that on Dec. 29, 2011, ... Total Artificial Heart patient, 61-year-old Nikola Gaspic, to ... using the Freedom® portable driver . ...
... -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... that specializes in patented biopharmaceutical medicine, modernized ... active pharmaceutical ingredients (API) announced the Company ... certification for its 250-ton Jiangchuan Macrolide Facility ...
...  Synthetic Genomics Inc. (SGI), a privately held company commercializing ... of global challenges, today announced they have hired George ... is a proven leader with experience in developing sophisticated ... and nutritional products for humans and animals. At SGI ...
Cached Biology Technology:Slovenia's 1st Total Artificial Heart Patient Discharged from UMC Ljubljana Using the FreedomĀ® Portable Driver 2Slovenia's 1st Total Artificial Heart Patient Discharged from UMC Ljubljana Using the FreedomĀ® Portable Driver 3TPI Receives GMP Certification for JCM Facility 2TPI Receives GMP Certification for JCM Facility 3Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program 2
(Date:9/16/2014)... The risk of severe maternal morbidity amongst women ... suggests a new study published today (17 September) ... and Gynaecology . , Australians generally enjoy high ... that health disparities exist, in particular between indigenous ... aimed to explore the independent impact of socioeconomic ...
(Date:9/16/2014)... YORK (17 September, 2014)More than $100 trillion in ... of annual carbon dioxide (CO2)a 40 percent reduction ... 2050 if the world expands public transportation, walking ... report released by the University of California, Davis, ... (ITDP). , Further, an estimated 1.4 million ...
(Date:9/16/2014)... Pit Fire began on September 13, 2014. The fire ... is currently over 2,300 acres in size and is mostly ... Pit Fire was calm Monday night due to higher humidity. ... anchor point and beginning to construct a fireline on the ... resources are working on the fire: , 7 20-person Crews, ...
Breaking Biology News(10 mins):New study examines the impact of socioeconomic position & maternal morbidity in Australia 2New study examines the impact of socioeconomic position & maternal morbidity in Australia 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 2Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 3Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 4Global shift away from cars saves US$100 trillion, eliminates 1,700 MT of CO2 pollution 5
... Obese women are as much as 28 percent ... pregnancy, according to research that earned a Michigan State ... Barbara Luke, a researcher in the MSU College of ... focused on data of nearly 50,000 women using assisted ...
... the UCLA Henry Samueli School of Engineering and Applied ... the laboratory the enzyme responsible for producing the blockbuster ... published Oct. 23 in the journal Science , ... with similarly beneficial effects. The ...
... at Chicago have received $1 million from the National ... between "fat taxes" and food consumption, diet quality and ... made available through the American Recovery and Reinvestment Act ... rates associated with restaurants and with specific sugar- and ...
Cached Biology News:MSU researcher: Obesity significantly cuts odds of successful pregnancy 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2
... SDSaway reagent is a valuable tool for ... The presence of SDS in biological samples ... bound SDS-protein complex, inhibits enzymatic activity during ... as a contaminant in mass spectrometry analyses. ...
... cGMP Safe Deposit Service ECACC is able ... requirements of cGMP for cryo-storage. The cell lines ... they have been produced in accordance with the ... tested for freedom from mycoplasma, bacteria or fungi. ...
Standard and modified oligonucleotides up to 150 nt-long at any scale for broad applications. Price starts from 30p/base (10 nmole scale)....
... has 20 years of expertise in the ... still offers the most powerful systems on ... to 40 000 in-microplate tests requiring incubation ... of different modules (such as worktable shaker ...
Biology Products: